Hemostemix
CompanyCanada
Hemostemix develops one asset, in phase 1 (VesCell in angina). Mostly cell therapy; based in Canada.
- 1
- Asset
- Furthest stage
- Phase 1
- 0
- Trials
- 0
- Signals
Pipeline
1Autologous angiogenic cells promote blood vessel formation to improve tissue perfusion.
Phase 1, Cell therapy, angina, pain
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies6